4//SEC Filing
Salzmann Peter 4
Accession 0001764013-25-000049
CIK 0001764013other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:46 PM ET
Size
7.5 KB
Accession
0001764013-25-000049
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Salzmann Peter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-04-01+265,820→ 1,214,606 total - Award
Stock Option (right to buy)
2025-04-01+374,395→ 374,395 totalExercise: $15.20Exp: 2035-04-01→ Common Stock (374,395 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 1, 2026, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]The shares underlying the options will vest as to 25% of the shares on April 1, 2026 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001796309
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:46 PM ET
- Size
- 7.5 KB